Inactive Instrument

Quotes Atrinsic, Inc. Other OTC

Stocks

End-of-day quote Other OTC
- ^USD	-

20/08	Protagenic Therapeutics Receives Fda Pre-Ind Feedback Supporting New Ind for Pt00114 in Generalized Anxiety Disorder	CI
20/08	Protagenic Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Stock exchange

Market Cap (USD)

21,49,714

Net sales ()

Date	Opening	High	Low	Close	Volume	Change

Duration

Period